Machine Learning

In an age of AI traders and instant data, one expert argues that the most valuable asset remains timeless: human discipline. But is this enough to navigate our volatile future?

Arcfra's AKE 1.6 release tackles Kubernetes complexity with visual tools while hardening security with advanced network isolation for mission-critical systems.

Light AI's smartphone diagnostic tool enters a crucial New Zealand study, but can its innovative tech overcome financial pressures and regulatory hurdles?

PSignite's latest award highlights a hard truth for CPG leaders: the most powerful AI is worthless if your team won't use it. Here's the real story.

A new camera-free, ultra-low-power eye sensor promises to understand your intent, not just your commands, potentially solving the biggest problems in wearables.

Nordicus Partners reveals promising data for gum disease and oral lesions, betting its future on a unique Nordic acquisition strategy and a Nasdaq uplisting.

As event spending soars, the gap between CMOs and CFOs widens. A new summit aims to forge a tech-driven truce with a new financial model.

At Automate 2026, Taiwan isn't just selling robots. It's offering a strategic partnership to rebuild U.S. manufacturing with its advanced AI and automation.

With Intel's new Panther Lake chips, ARBOR Technology is moving AI model training from the cloud to the device, promising a new era of truly adaptive automation.

BetterAge's new executive team signals a potent strategy: combining deep industry partnerships with advanced AI to scale in the competitive elder care market.

Whimstay's new feature lets you book a vacation home hours before check-in, challenging hotels and solving the industry's spontaneity problem.

At VivaTech 2026, JCDecaux unveiled a bus shelter that fights heatwaves and AI-driven ads, blurring the line between public service and modern commerce.

As AI's hunger for processing power outstrips supply, a new class of specialized cloud providers is emerging to challenge the giants. But can they deliver?

A defense tech investor's bet on a Databricks partner reveals a crucial truth: the AI revolution will be built not by algorithms alone, but by modernizing data.

As AI drug discovery faces a crucial test, Terray Therapeutics hires a proven dealmaker. Can Lisa Decker translate digital promise into clinical reality?

Big Pharma is pouring over $1 billion into AI to design complex drugs, trading lab guesswork for algorithms. It's a high-stakes play to fix a broken R&D model.

A small-town medical spa is investing in cutting-edge tech for body, bladder, and brain. Is this the future of healthcare or a high-stakes gamble?

With 6,000 users in under a year, Smart Clerk's AI platform is gaining traction. We analyze the real-world gains and critical limitations for entrepreneurs.

Elevance Health is deploying a suite of AI-driven tools to manage chronic illness. Is this the future of healthcare or just a new set of digital hurdles?

Boy George's 'Karma Chameleon' gets an AI-assisted update. A new model from Syntiant and Artist Included promises to honor legacies, not erase them.